| 期 |
标题 |
文件 |
| 卷 31, 编号 38 (2024) |
A Systematic Patent Review (2008-2023) for Treatment in Pregnancy |
(Eng)
|
|
Pereira K., Pacheco C., Alves I., Haas S.
|
| 卷 31, 编号 39 (2024) |
Identification of Crosstalk Genes between Lung Adenocarcinoma and Periodontitis |
(Eng)
|
|
Wang P., Yu H., Gao X., Guo Z., Zhang Z., Wang Z.
|
| 卷 31, 编号 4 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Amoroso R.
|
| 卷 31, 编号 4 (2024) |
Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder |
(Eng)
|
|
De S.
|
| 卷 31, 编号 4 (2024) |
Herbal Substances with Antiviral Effects: Features and Prospects for the Treatment of Viral Diseases with Emphasis on Pro-Inflammatory Cytokines |
(Eng)
|
|
Bjørklund G., Lysiuk R., Semenova Y., Lenchyk L., Dub N., Doşa M., Hangan T.
|
| 卷 31, 编号 4 (2024) |
Research Status, Synthesis and Clinical Application of Antiepileptic Drugs |
(Eng)
|
|
Wang S., Zhao M., Zhao P., Zhang W., Rao G.
|
| 卷 31, 编号 4 (2024) |
Novel Perspectives for the Diagnosis and Treatment of Gynecological Cancers using Dysregulation of PIWI Protein and PiRNAs as Biomarkers |
(Eng)
|
|
Yousefi B., Sadoughi F., Asemi Z., Mansournia M., Hallajzadeh J.
|
| 卷 31, 编号 4 (2024) |
Recent Advances and Techniques for Identifying Novel Antibacterial Targets |
(Eng)
|
|
Qiu J., Tang Z., He Y., Nazli A.
|
| 卷 31, 编号 4 (2024) |
Does Quinoa (Chenopodium quinoa) Consumption Improve Blood Glucose, Body Weight and Body Mass Index? A Systematic Review and Dose-Response Meta-Analysis of Clinical Trials |
(Eng)
|
|
Atefi M., Heidari Z., Shojaei M., Askari G., Kesharwani P., Bagherniya M., Sahebkar A.
|
| 卷 31, 编号 40 (2024) |
Novel Anti-tumor Bio-drugs and Therapeutic Strategies in Cancer Management: From Bench to Translational Research |
(Eng)
|
|
Huang S.
|
| 卷 31, 编号 40 (2024) |
Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer |
(Eng)
|
|
Alnukhali M., Altabbakh O., Farooqi A., Pollack A., Daunert S., Deo S., Tao W.
|
| 卷 31, 编号 39 (2024) |
Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds |
(Eng)
|
|
Nian C., Gan X., Liu Q., Wu Y., Kong M., Zhang P., Jin M., Dong Z., Li W., Wang L., He W., Li X., Wu J.
|
| 卷 31, 编号 39 (2024) |
Does Eta Protein Differentiate Rheumatoid Arthritis from Psoriatic Arthritis? |
(Eng)
|
|
Kor A., Orhan K., Maraş Y., Oğuz E., Unan M., Dilek G., Erten Ş., Nas K.
|
| 卷 31, 编号 39 (2024) |
The use of SP/Neurokinin-1 as a Therapeutic Target in Colon and Rectal Cancer |
(Eng)
|
|
Martín-García D., Téllez T., Redondo M., García-Aranda M.
|
| 卷 31, 编号 38 (2024) |
Differential Effect of 4H-Benzo[d] [1, 3]oxazines on the Proliferation of Breast Cancer Cell Lines |
(Eng)
|
|
Fraire-Soto I., Araujo-Huitrado J., Granados-López A., Segura-Quezada L., Ortiz-Alvarado R., Herrera M., Gutiérrez-Hernández R., Reyes-Hernández C., López-Hernández Y., Tapia-Juárez M., Negrete-Díaz J., Chacón-García L., Solorio-Alvarado C., López J.
|
| 卷 31, 编号 38 (2024) |
A Novel Gene Signature based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients |
(Eng)
|
|
Ma C.
|
| 卷 31, 编号 38 (2024) |
Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site Inhibitors |
(Eng)
|
|
Shihab W., Kubba A., Tahtamouni L., Saleh K., AlSakhen M., Kanaan S., Saleh A., Yasin S.
|
| 卷 31, 编号 38 (2024) |
Multi-omics Data Integration Analysis Identified Therapeutic Targets and Potential Reuse Drugs for Osteoporosis |
(Eng)
|
|
Li M., Gao X., Zhang Y., Wang J., Dong R., Li P., He Y.
|
| 卷 31, 编号 39 (2024) |
PLGA Nanoparticles as New Drug Delivery Systems in Leishmaniasis Chemotherapy: A Review of Current Practices |
(Eng)
|
|
Valiallahi A., Vazifeh Z., Gatabi Z., Davoudi M., Gatabi I.
|
| 卷 31, 编号 39 (2024) |
The Roles of Endogenous D2R Dopamine and µ-opioid Receptors of the Brain in Alcohol use Disorder |
(Eng)
|
|
Khikhmetova K., Semenova Y., Bjørklund G.
|
| 卷 31, 编号 39 (2024) |
The Association between High-density Lipoproteins and Periodontitis |
(Eng)
|
|
Ehteshami A., Shirban F., Bagherniya M., Sathyapalan T., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 39 (2024) |
Roles of PCSK9 in the Pathogenesis of Periodontal Disease |
(Eng)
|
|
Khosrojerdi M., Reiner ., Vatanparast N., Jamialahmadi T., Kesharwani P., Sahebkar A.
|
| 卷 31, 编号 39 (2024) |
Application Research Progress of Nanomaterial Graphene and its Derivative Complexes in Tumor Diagnosis and Therapy |
(Eng)
|
|
Cui L., Fan L., Shen Z.
|
| 卷 31, 编号 39 (2024) |
Association of Neurokinin-1 Receptor Signaling Pathways with Cancer |
(Eng)
|
|
Rodriguez F., Covenas R.
|
| 卷 31, 编号 40 (2024) |
Artificial Intelligence Application for Anti-tumor Drug Synergy Prediction |
(Eng)
|
|
Peng Z., Ding Y., Zhang P., Lv X., Li Z., Zhou X., Huang S.
|
| 卷 31, 编号 40 (2024) |
Evaluation of Treatments with Radiotherapy Alone and Radiotherapy Plus Chemo-immunotherapy in Patients with Primary Liver Cancer based on Blood Biomarkers |
(Eng)
|
|
Huang S., Yin Y., Li J., Shi M., Bian H., Zhao L.
|
| 卷 31, 编号 41 (2024) |
MicroRNA Profiles in Critically Ill Patients |
(Eng)
|
|
Alikiaii B., Bagherniya M., Askari G., Rajendram R., Sahebkar A.
|
| 卷 31, 编号 41 (2024) |
Curcumin Derivatives Linked to a Reduction of Oxidative Stress in Mental Dysfunctions and Inflammatory Disorders |
(Eng)
|
|
Dhiman P., Malik N.
|
| 卷 31, 编号 41 (2024) |
Marine Bacteria: A Source of Novel Bioactive Natural Products |
(Eng)
|
|
Zha X., Ji R., Zhou S.
|
| 卷 31, 编号 41 (2024) |
From Plants to Therapies: Exploring the Pharmacology of Coumestrol for Neurological Conditions |
(Eng)
|
|
Singla M., Verma S., Thakur K., Goyal A., Sharma V., Sharma D., Porwal O., Subramaniyan V., Behl T., Singh S., Dua K., Gupta G., Gupta S.
|
| 卷 31, 编号 41 (2024) |
Development and Validation of the Diagnostic Model of 7 Gene in Endometriosis |
(Eng)
|
|
Zhu R., Liu Y., Zhou J., Lv Z., Shi K., Xiong J.
|
| 卷 31, 编号 41 (2024) |
Evidence from Machine Learning, Diagnostic Hub Genes in Sepsis and Diagnostic Models based on Xgboost Models, Novel Molecular Models for the Diagnosis of Sepsis |
(Eng)
|
|
Yu Y., Li J., Li J., Zen X., Fu Q.
|
| 卷 31, 编号 41 (2024) |
Rituximab Combined with Steroid and Tacrolimus Treats Proliferative Glomerulonephritis with Monoclonal IgG Deposits: A Case Report and Review of the Literature |
(Eng)
|
|
Liu D., Xia M., Wang C., Zhu X., Chen G., Liu H.
|
| 卷 31, 编号 42 (2024) |
Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis? |
(Eng)
|
|
Orekhov A., Sukhorukov V., Melnichenko A.
|
| 卷 31, 编号 42 (2024) |
Porphyrinuria in Autism Spectrum Disorder: A Review |
(Eng)
|
|
Bjørklund G., Semenova Y., El-Ansary A., Al-Ayadhi L.
|
| 卷 31, 编号 42 (2024) |
The Link between miRNAs and PCKS9 in Atherosclerosis |
(Eng)
|
|
Macvanin M., Gluvic Z., Klisic A., Manojlovic M., Suri J., Rizzo M., Isenovic E.
|
| 卷 31, 编号 41 (2024) |
Periodontitis Continuum: Antecedents, Triggers, Mediators, and Treatment Strategies |
(Eng)
|
|
Gasmi Benahmed A., Tippairote T., Gasmi A., Noor S., Avdeev O., Shanaida Y., Mojgani N., Emadali A., Dadar M., Bjørklund G.
|
| 卷 31, 编号 41 (2024) |
Caffeic Acid Phenethyl Ester: A Potential Therapeutic Cancer Agent? |
(Eng)
|
|
Bjørklund G., Storchylo O., Peana M., Hangan T., Lysiuk R., Lenchyk L., Koshovyi O., Antonyak H., Hudz N., Chirumbolo S.
|
| 卷 31, 编号 41 (2024) |
Advances in the Development of Carbonic Anhydrase Inhibitors as New Antiprotozoal Agents |
(Eng)
|
|
Ortiz-Perez E., Vazquez-Jimenez L., Paz-Gonzalez A., Delgado-Maldonado T., González-González A., Gaona-Lopez C., Moreno-Herrera A., Vazquez K., Rivera G.
|
| 卷 31, 编号 40 (2024) |
Novel Natural Inhibitors for Glioblastoma by Targeting Epidermal Growth Factor Receptor and Phosphoinositide 3-kinase |
(Eng)
|
|
Ullah A., Ullah S., Waqas M., Khan M., Rehman N., Khalid A., Jan A., Aziz S., Naeem M., Halim S., Khan A., Al-Harrasi A.
|
| 卷 31, 编号 40 (2024) |
Rhodotorulic Acid and its Derivatives: Synthesis, Properties, and Applications |
(Eng)
|
|
Stefaniak J., Nowak M., Skwarecki A.
|
| 卷 31, 编号 40 (2024) |
Effects of Consuming Repeatedly Heated Edible Oils on Cardiovascular Diseases: A Narrative Review |
(Eng)
|
|
Soundararajan P., Parthasarathy S., Sakthivelu M., Karuppiah K., Velusamy P., Gopinath S., Raman P.
|
| 卷 31, 编号 40 (2024) |
Fluvastatin: A Choice for COVID-19-associated Mucormycosis Management |
(Eng)
|
|
Tavakkoli A., Johnston T., Sahebkar A.
|
| 卷 31, 编号 40 (2024) |
Research Progress of Pyroptosis in Renal Diseases |
(Eng)
|
|
Hu B., Ma K., Wang W., Han Z., Chi M., Nasser M., Liu C.
|
| 卷 31, 编号 40 (2024) |
Strategic and Innovative Roles of lncRNAs Regulated by Naturally-derived Small Molecules in Cancer Therapy |
(Eng)
|
|
Hale Alkan A., Ensoy M., Cansaran-Duman D.
|
| 卷 31, 编号 40 (2024) |
Multi-omics Combined with Machine Learning Facilitating the Diagnosis of Gastric Cancer |
(Eng)
|
|
Li J., Xu S., Zhu F., Shen F., Zhang T., Wan X., Gong S., Liang G., Zhou Y.
|
| 卷 31, 编号 40 (2024) |
Synthesis and Anti-bacterial Activity of New Substituted 2-trifluoromethyl-4-quinolinylhydrazone Analogs against Mycobacterium tuberculosis Strains |
(Eng)
|
|
da Silva E., de Andrade G., Lourenço M., De Souza M.
|
| 卷 31, 编号 40 (2024) |
Quantitative Structure-activity Relationship (QSAR) Modelling of Indomethacin Derivatives using Regression Analysis |
(Eng)
|
|
Shukla N., Sharma B.
|
| 卷 31, 编号 41 (2024) |
Urinary miRNAs and Prostate Cancer: Is there a Crossover Point Eventually, and where should we Head? |
(Eng)
|
|
Giannakodimos I.
|
| 卷 31, 编号 42 (2024) |
The Beneficial Effects of Curcumin on Lipids: Possible Effects on Dyslipidemia-induced Cardiovascular Complications |
(Eng)
|
|
Yaribeygi H., Maleki M., Butler A., Jamialahmadi T., Gumpricht E., Sahebkar A.
|
| 卷 31, 编号 32 (2024) |
A Novel Phytocolorant, Neoxanthin, as a Potent Chemopreventive: Current Progress and Future Prospects |
(Eng)
|
|
Parida S., Jena M., Behera A., Mandal A., Nayak R., Patra S.
|
| 卷 31, 编号 33 (2024) |
Human Umbilical Cord Mesenchymal Stem Cell Exosome-derived miR-335-5p Alleviated Lipopolysaccharide-induced Acute Lung Injury by Regulating the m6A Level of ITGβ4 Gene |
(Eng)
|
|
Li L., Zhang X., Chen Y.
|
| 卷 31, 编号 33 (2024) |
An Investigation of Pharmacokinetic Interaction of Vericiguat with Apigenin based on a Newly Developed Ultra-performance Liquid Chromatography-tandem Mass Spectrometry Assay |
(Eng)
|
|
Zhang E., Chen C., Wang Y., Weng Q., Xu R., Lin J.
|
| 卷 31, 编号 33 (2024) |
New Pyrrolopyrimidines as LRRK2 Inhibitors for Treating Parkinson's Disease |
(Eng)
|
|
De S.
|
| 卷 31, 编号 34 (2024) |
Medicinal (Radio) Chemistry: Building Radiopharmaceuticals for the Future |
(Eng)
|
|
Pijeira M., Nunes P., Chaviano S., Diaz A., DaSilva J., Ricci-Junior E., Alencar L., Chen X., Santos-Oliveira R.
|
| 卷 31, 编号 34 (2024) |
Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview |
(Eng)
|
|
Khator R., Biharee A., Bhatia N., Kulkarni S., Singh Y., Karthikeyan C., Jain A., Thareja S.
|
| 卷 31, 编号 34 (2024) |
Phytochemicals as Substances that Affect Astrogliosis and their Implications for the Management of Neurodegenerative Diseases |
(Eng)
|
|
Forouzanfar F., Pourbagher-Shahri A., Vafaee F., Sathyapalan T., Sahebkar A.
|
| 卷 31, 编号 34 (2024) |
CircRNAs as a Novel Class of Potential Diagnostic Biomarkers in Bipolar Disorders |
(Eng)
|
|
Asemi R., Ebrahimi A., Hamblin M., Mirzaei H., Asemi Z.
|
| 卷 31, 编号 34 (2024) |
Regulatory Non-coding RNAs Involved in Oxidative Stress and Neuroinflammation: An Intriguing Crosstalk in Parkinsons Disease |
(Eng)
|
|
Khish N., Ghiasizadeh P., Rasti A., Moghimi O., Zadeh A., Bahiraee A., Ebrahimi R.
|
| 卷 31, 编号 34 (2024) |
Non-oxidative Modified Low-density Lipoproteins: The Underappreciated Risk Factors for Atherosclerosis |
(Eng)
|
|
Zhao Y., Xu Q., He N., Jiang M., Chen Y., Ren Z., Tang Z., Wu C., Liu L.
|
| 卷 31, 编号 34 (2024) |
The Pharmacokinetic Interaction of Tirabrutinib with Voriconazole, Itraconazole, and Fluconazole in SD Rats by UPLC-MS/MS |
(Eng)
|
|
Xia M., Liu Y., Chen J., Xu R., Dai G.
|
| 卷 31, 编号 33 (2024) |
Identifying Luteolin as a Potential Drug for Treating Lung Adenocarcinoma with COVID-19 Affection based on Integration Analysis of Pharmacology and Transcriptome |
(Eng)
|
|
Peng P., Li N., Zhang N., Fu X., Peng S., Zhao Y., Ai B.
|
| 卷 31, 编号 33 (2024) |
Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme |
(Eng)
|
|
Li Z., Jin Y., Que T., Zhang X., Yi G., Zheng H., Yuan X., Wang X., Xu H., Nan J., Chen C., Wu Y., Huang G.
|
| 卷 31, 编号 33 (2024) |
Curcuminoid Chalcones: Synthesis and Biological Activity against the Human Colon Carcinoma (Caco-2) Cell Line |
(Eng)
|
|
Olender D., Sowa-Kasprzak K., Pawełczyk A., Skóra B., Zaprutko L., Szychowski K.
|
| 卷 31, 编号 32 (2024) |
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy |
(Eng)
|
|
Vijayan Y., Sandhu J., Harikumar K.
|
| 卷 31, 编号 32 (2024) |
Cancer Pathways Targeted by Berberine: Role of microRNAs |
(Eng)
|
|
Ali M., Mishra D., Singh R.
|
| 卷 31, 编号 32 (2024) |
Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma |
(Eng)
|
|
Rayginia T., Keerthana C., Shifana S., Pellissery M., Abhishek A., Anto R.
|
| 卷 31, 编号 32 (2024) |
Targeting Cervical Cancer Stem Cells by Phytochemicals |
(Eng)
|
|
Tripathi T., Yadav J., Janjua D., Chaudhary A., Joshi U., Senrung A., Chhokar A., Aggarwal N., Bharti A.
|
| 卷 31, 编号 32 (2024) |
The Potential of Epigallocatechin Gallate in Targeting Cancer Stem Cells: A Comprehensive Review |
(Eng)
|
|
Chaudhuri R., Samanta A., Saha P., Ghosh S., Sinha D.
|
| 卷 31, 编号 32 (2024) |
Natures Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization |
(Eng)
|
|
Kumari R., Syeda S., Shrivastava A.
|
| 卷 31, 编号 33 (2024) |
AI: A New Solution for Old Issues of Carotid Atherosclerotic Plaque |
(Eng)
|
|
Boccatonda A., Cocco G., Schiavone C.
|
| 卷 31, 编号 33 (2024) |
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021 |
(Eng)
|
|
Duncan C., Gunosewoyo H., Mocerino M., Payne A.
|
| 卷 31, 编号 33 (2024) |
Radiotherapy-associated Sensorineural Hearing Loss in Pediatric Oncology Patients |
(Eng)
|
|
Aslam M., Ahmad H., Malik H., Uinarni H., Karim Y., Akhmedov Y., Abdelbasset W., Awadh S., Abid M., Mustafa Y., Farhood B., Sahebkar A.
|
| 卷 31, 编号 33 (2024) |
The Metformin Immunoregulatory Actions in Tumor Suppression and Normal Tissues Protection |
(Eng)
|
|
Gupta J., Jalil A., Abd Alzahraa Z., Aminov Z., Alsaikhan F., Ramírez-Coronel A., Ramaiah P., Najafi M.
|
| 卷 31, 编号 34 (2024) |
Molecular Subtypes and Prognostic Models for Predicting Prognosis of Lung Adenocarcinoma based on MiRNA-related Genes |
(Eng)
|
|
Wei Y., Zhong W., Bi Y., Liu X., Zhou Q., Liu J., Wang M., Zhang H., Chen M.
|
| 卷 31, 编号 34 (2024) |
Role of S100 and YKL40 on Intraventricular Cerebral Hemorrhages in the Preterm Infant and the Neuroprotective Role of miR-138- siRNAs-HIF-1a and miR-21-siRNAs-HVCN1 in Neonatal Mice with Nerve Injury |
(Eng)
|
|
Ijabi R., Kaminsky Z., Roozehdar P., Ijabi J., Moradi-Sardareh H., Tehranian N.
|
| 卷 31, 编号 37 (2024) |
Recent Advances in the Synthesis and Analysis of Atorvastatin and its Intermediates |
(Eng)
|
|
Li S., Zhang W., Zhang W., Huang A., Zhu J., Wang Y., Zheng Y.
|
| 卷 31, 编号 37 (2024) |
Exosomal Non-coding RNAs: A New Approach to Melanoma Diagnosis and Therapeutic Strategy |
(Eng)
|
|
Liu J., Hu X., Xin W., Wang X.
|
| 卷 31, 编号 37 (2024) |
Biochemistry, Mechanistic Intricacies, and Therapeutic Potential of Antimicrobial Peptides: An Alternative to Traditional Antibiotics |
(Eng)
|
|
Dwivedi M., Parmar M., Mukherjee D., Yadava A., Yadav H., Saini N.
|
| 卷 31, 编号 37 (2024) |
LncRNA MEG3: Targeting the Molecular Mechanisms and Pathogenic causes of Metabolic Diseases |
(Eng)
|
|
Luo Y., Wang H., Wang L., Wu W., Zhao J., Li X., Xiong R., Ding X., Yuan D., Yuan C.
|
| 卷 31, 编号 37 (2024) |
Polyphenolic Nano-formulations: A New Avenue against Bacterial Infection |
(Eng)
|
|
Farhadi F., Eghbali S., Torabi Parizi S., Jamialahmadi T., Gumpricht E., Sahebkar A.
|
| 卷 31, 编号 37 (2024) |
In Silico Screening and Molecular Dynamics Simulations against Tyrosine-protein Kinase Fyn Reveal Potential Novel Therapeutic Candidates for Bovine Papillomatosis |
(Eng)
|
|
Barros G., Barreto D., Cavalcanti S., Oliveira T., Rodrigues R., de Aragão Batista M.
|
| 卷 31, 编号 38 (2024) |
Advances of Oxidative Stress Impact in Periodontitis: Biomarkers and Effective Targeting Options |
(Eng)
|
|
Pouliou C., Piperi C.
|
| 卷 31, 编号 38 (2024) |
Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor |
(Eng)
|
|
Jiang Y., Wu Y., Wang J., Ma Y., Yu H., Wang Z.
|
| 卷 31, 编号 38 (2024) |
1,3,4-Oxadiazole: An Emerging Scaffold to Inhibit the Thymidine Phosphorylase as an Anticancer Agent |
(Eng)
|
|
Murmu A., Banjare P., Matore B., Roy P., Singh J.
|
| 卷 31, 编号 38 (2024) |
Neuroprotective Effect of Natural Indole and β-carboline Alkaloids against Parkinsons Disease: An Overview |
(Eng)
|
|
Shome A., Chahat ., Chawla V., Chawla P.
|
| 卷 31, 编号 37 (2024) |
Recent Advancements in the Treatment of Alzheimers Disease: A Multitarget-directed Ligand Approach |
(Eng)
|
|
Kumar S., Mahajan A., Ambatwar R., Khatik G.
|
| 卷 31, 编号 37 (2024) |
The Role of the Vagus Nerve in the Microbiome and Digestive System in Relation to Epilepsy |
(Eng)
|
|
Rubio C., Ochoa E., Gatica F., Portilla A., Vázquez D., Rubio-Osornio M.
|
| 卷 31, 编号 37 (2024) |
Exploring the Role of Nitric Oxide in Lower Airway Diseases: Insights and Real-world Application |
(Eng)
|
|
Ambrosino P., Marcuccio G., Maniscalco M.
|
| 卷 31, 编号 34 (2024) |
Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other Diseases |
(Eng)
|
|
De S.
|
| 卷 31, 编号 35 (2024) |
The Protective Effects of Curcumin against Renal Toxicity |
(Eng)
|
|
Zhai J., Chen Z., Zhu Q., Guo Z., Wang N., Zhang C., Deng H., Wang S., Yang G.
|
| 卷 31, 编号 35 (2024) |
EPHA2 Receptor as a Possible Therapeutic Target in Viral Infections |
(Eng)
|
|
Vincenzi M., Mercurio F., Leone M.
|
| 卷 31, 编号 35 (2024) |
Recent Developments in Coumarin Derivatives as Neuroprotective Agents |
(Eng)
|
|
Mishra P., Kumar A., Kaur K., Jaitak V.
|
| 卷 31, 编号 35 (2024) |
Nucleoside Scaffolds and Carborane Clusters for Boron Neutron Capture Therapy: Developments and Future Perspective |
(Eng)
|
|
Khalil A., Adam M.
|
| 卷 31, 编号 35 (2024) |
Mechanisms of the Quorum Sensing Systems of Pseudomonas aeruginosa: Host and Bacteria |
(Eng)
|
|
Flores-Percino D., Osorio-Llanes E., Sepulveda Y., Castellar- López J., Madera R., Rada W., Meléndez C., Mendoza-Torres E.
|
| 卷 31, 编号 35 (2024) |
The Potential Therapeutic Applications of CRISPR/Cas9 in Colorectal Cancer |
(Eng)
|
|
Pourali G., Maftooh M., Akbarzade H., Hassanian S., Mobarhan M., Ferns G., Khazaei M., Avan A., Sahranavard T., Mehrabadi S.
|
| 卷 31, 编号 35 (2024) |
The Mechanisms of miRNAs on Target Regulation and their Recent Advances in Atherosclerosis |
(Eng)
|
|
Yin R., Lu H., Cao Y., Zhang J., Liu G., Guo Q., Kai X., Zhao J., Wei Y.
|
| 卷 31, 编号 35 (2024) |
The Tao of Copper Metabolism: From Physiology to Pathology |
(Eng)
|
|
Gao S., Zhou M., Tang Z.
|
| 卷 31, 编号 35 (2024) |
Current Evidence on Dietary Factors and Kidney Allograft Function in Kidney Transplant Recipients: A Systematic Review |
(Eng)
|
|
Nosrati-Oskouie M., Salavatizadeh M., Ghorban Sabbagh M., Aghili-Moghaddam N., Tarighat-Esfanjani A., Sahebkar A.
|
| 卷 31, 编号 38 (2024) |
Drug Repurposing against Novel Therapeutic Targets in Plasmodium falciparum for Malaria: The Computational Perspective |
(Eng)
|
|
Rai S., Shukla S., Scotti L., Mani A.
|
| 1 - 100 的 400 信息 |
1 2 3 4 > >>
|
